February 2020 Meeting
Topic: An overview of cosmetic product safety evaluation
Safety assessments of cosmetic ingredients and products are based on evaluations of the risk they pose. Risk is defined as the probability of harm relative to dose and exposure. Hazard based safety assessment looks only at the potential to cause injury, but with no relation to dose or exposure. Cosmetic industry uses a number of tools to evaluate the risk of ingredients and products before they have entered the market, as well as once they are already made available to consumers. This talk aims at presenting the industry approach to the safety assessment of cosmetics and personal care products. An overview of the four-step, science-based process of exposure-based risk assessment for the ingredients will be provided. Considerations for clinical safety testing, safety claim substantiation, and animal alternative methodologies for product safety evaluation will be also discussed.
Dr. Farahmand is a is a skin scientist and consumer product toxicologist with multi-disciplinary experience in personal care and consumer product Industries. Her areas of expertise include skin absorption, dermatopharmaceutics, dermal toxicology, and exposure-based risk assessment including animal-alternatives risk assessment methodologies, clinical safety, safety claim substantiation, and formulation of cosmetic/topical drug products.
She is currently a Sr. toxicologist at Clorox where she leads the safety program for a diverse portfolio that includes company’s specialty business and fragrance program as well as working with state regulators and trade associations and leading external strategic communications. She had the opportunity of working as a Regulatory Toxicologist/Safety Manager in other multinational companies (including Procter and Gamble, Avon products, Georgia pacific and Living Proof, Inc.) leading safety programs of wide range of cosmetic, personal care and consumer products including products intended for use in sensitive populations.
Dr. Farahmand held two postdoctoral fellowship positions at the department of dermatology, University of California, San Francisco, and at the college of pharmacy, the University of Cincinnati, where she worked on developing in vitro and in silico models of estimating dermal absorption, characterizing skin barrier structure and function, dermal irritation, understanding the factors influencing dermal bioavailability, and the correlation of epidermal bioavailability and skin sensitization. She has received her doctorate in Pharmaceutical Sciences from the University of Tehran, Iran.
|Event Date||February 25, 2020 5:00 pm|
|Event End Date||February 25, 2020 8:30 pm|
|Location||Warner Center Marriott (Woodland Hills)|